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SOCS3 Is a Critical Physiological
Negative Regulator of G-CSF Signaling
and Emergency Granulopoiesis
(Jaks) and phosphorylation of one or more tyrosine resi-
dues in the C-terminal region of the receptor and activa-
tion of multiple intracellular signaling proteins, including
the signal transducers and activators of transcription
(STAT) and mitogen-activated protein (MAP) kinases
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The suppressor of cytokine signaling (SOCS) proteinsAustralia
are attractive candidates as negative regulators of cyto-
kine signaling. They are induced as part of the cellular
response to cytokine stimulation and are thought toSummary
act within a classical negative feedback loop to inhibit
activation of signaling pathways and target signalingTo determine the importance of suppressor of cyto-
components for proteasomal degradation (Endo et al.,kine signaling-3 (SOCS3) in the regulation of hemato-
1997; Kamura et al., 1998; Naka et al., 1997; Starr et al.,poietic growth factor signaling generally, and of G-CSF-
1997; Zhang et al., 1999).induced cellular responses specifically, we created mice
With respect to G-CSF, current data suggest that ofin which the Socs3 gene was deleted in all hematopoi-
the SOCS family, SOCS3 is the most likely candidate asetic cells. Although normal until young adulthood, these
a physiological regulator of cellular responses to thismice then developed neutrophilia and a spectrum of
cytokine. SOCS3 expression is induced in primary my-inflammatory pathologies. When stimulated with G-CSF
eloid cells when stimulated by G-CSF (Hortner et al.,in vitro, SOCS3-deficient cells of the neutrophilic gran-
2002; Lee et al., 2002). SOCS3 binds selectively to theulocyte lineage exhibited prolonged STAT3 activation
human G-CSFR at tyrosine 729 (Y728 for the murineand enhanced cellular responses to G-CSF, including
G-CSFR) when this residue is phosphorylated (pY729)an increase in cloning frequency, survival, and prolifer-
(Hortner et al., 2002). In cell-based overexpression sys-ative capacity. Consistent with the in vitro findings,
tems, binding of SOCS3 to pY729 inhibits STAT-depen-mutant mice injected with G-CSF displayed enhanced
dent gene expression after stimulation of the cell withneutrophilia, progenitor cell mobilization, and spleno-
G-CSF (Hortner et al., 2002). Evidence from mutationalmegaly, but unexpectedly also developed inflamma-
analyses in two distinct systems suggests that Y729-tory neutrophil infiltration into multiple tissues and
dependent regulation of STAT signaling is important forconsequent hind-leg paresis. We conclude that SOCS3
normal G-CSFR function in primary cells (Akbarzadehis a key negative regulator of G-CSF signaling in my-
et al., 2002; Hermans et al., 2002). First, primary hemato-eloid cells and that this is of particular significance
poietic progenitor cells exclusively expressing a mutant
during G-CSF-driven emergency granulopoiesis.
form of G-CSFR that has Y729 as the only functional
tyrosine residue responded to G-CSF in an aberrant
Introduction fashion: there was reduced G-CSF-induced colony for-
mation in semisolid cultures, and the number of cells
Granulocyte colony-stimulating factor (G-CSF) is the pri- within each colony was reduced by 50% on average
mary extracellular regulator of granulopoiesis, affecting (Hermans et al., 2002). In other experiments where pro-
the proliferation, survival, and differentiation of all cells genitor cells were stimulated through hybrid receptors
within the granulocytic lineage, from hematopoietic stem (EGF extracellular domain and G-CSFR intracellular do-
cells through to mature neutrophils (Lieschke et al., main) bearing inactivating mutations of Y729 (Y729F),
1994). Clinically, this activity is exploited to accelerate there was increased tritiated thymidine incorporation by
neutrophil recovery following chemotherapy and to mo- bone marrow cells and an increase in the proportion of
bilize stem and progenitor cells into the peripheral blood macrophage-containing colonies emergent after in vitro
for later use during hematopoietic stem cell transplanta- culture (Akbarzadeh et al., 2002). Taken together, these
tion (Duhrsen et al., 1988; Grigg et al., 1995; Sheridan data indicate that SOCS3 activity relies on binding to
et al., 1992). Y729, and that the presence of Y729 diminishes prolifer-
Dimerization of the extracellular domains of the G-CSF ative signals from the G-CSFR. A recent report has pos-
receptor (G-CSFR) results in activation of Janus kinases tulated that the increased granulocyte production ob-
served in mice with a conditional deletion of STAT3 was
related to the reduced SOCS3 expression observed in*Correspondence: roberts@wehi.edu.au
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STAT3-deficient myeloid cells for these mice (Lee et al., greater than 90% of B cells and nucleated erythroid
cells (Figure 1A).2002). A logical implication of these observations is that
SOCS3 is likely to be a negative regulator of proliferative
signals from the G-CSFR. Hematopoietic Cells from vavCreSocs3/fl
However, SOCS3 is not likely to be the only molecule Mice Are SOCS3 Deficient
to bind to phosphorylated Y729. For example, both We next generated vavCre transgenic mice and vavCre
SOCS3 and the tyrosine phosphatase SHP-2 bind to controls bearing various combinations of wild-type (),
the same phosphorylated tyrosine residue on the gp130 null (), or conditional (fl) Socs3 alleles. vavCreSocs3/fl
receptor (Bode et al., 2003; Lehmann et al., 2003; Nichol- mice, in which Socs3 is deleted in hematopoietic cells
son et al., 2000; Schmitz et al., 2000). In addition, much (Socs3/), appeared healthy at birth, developed nor-
of the key data summarized above derive from overex- mally, and proved fertile. In vavCreSocs3/fl mice, the
pression systems, which may not accurately reflect pri- Socs3 conditional allele was not detected in genomic
mary cell physiology. This latter point is particularly per- DNA of hematopoietic cells of all lineages in the adult
tinent for SOCS3 because negative effects on signaling bone marrow (BM), thymus, spleen, lymph nodes, and
from at least twenty other cytokine receptors have been progenitor cells, having been replaced by the deleted
observed when SOCS3 is overexpressed in cell lines allele () lacking the entire Socs3 coding region (Figure
(Alexander, 2002). Indeed, several reports have sug- 1B). While Socs3 transcripts are detectable at low levels
gested a role for SOCS3 in the negative regulation of in steady-state Socs3 wild-type bone marrow and are
interferon- receptor signaling (Karlsen et al., 2001; markedly induced by stimulation with G-CSF, Socs3/
Song and Shuai, 1998; Stoiber et al., 1999; Woldman et hematopoietic cells did not express Socs3 RNA at base-
al., 2001). However, this role could not be confirmed line or when stimulated with G-CSF (Figure 1C). Such
when tested in the more physiological context of SOCS3 high efficiency deletion is consistent with our previous
deficiency in hepatocytes and macrophages (Croker et experience of this conditional allele (Croker et al., 2003)
al., 2003; Lang et al., 2003). and greatly simplifies interpretation of the data to follow.
Therefore, to directly study the role of SOCS3 in the
regulation of G-CSF-induced cellular responses in vivo, Perturbed Hematopoiesis and Inflammatory Disease
and to more broadly determine which hematopoietic Develop in Aging vavCreSocs3/fl Mice
growth factors are regulated by SOCS3, we generated The majority of 8-week vavCreSocs3/fl mice displayed
mice in which hematopoietic cells lack SOCS3. A condi- normal hematocrit, platelet numbers, peripheral blood
tional gene targeting approach was necessary because counts, bone marrow cellularity, and splenic architec-
mice with germline deletion of Socs3 die of placental ture and cellularity (Table 1). One (of 70) 2-week-old
failure in utero (Marine et al., 1999; Roberts et al., 2001; vavCreSocs3/fl mouse displayed a neutrophil leukocy-
Takahashi et al., 2003), thereby preventing analysis of tosis and splenomegaly. However, from 17 weeks of
adult hematopoiesis. To overcome this, we created a age, an illness characterized by inflammation in the pleu-
loxP-flanked Socs3 allele (Socs3fl) (Croker et al., 2003) ral and peritoneal cavities, neutrophil leukocytosis, and
and transgenic mice in which expression of Cre recom- infiltration of liver and lungs by hematopoietic cells from
binase was directed to hematopoietic cells by use of multiple lineages (Figure 2) became increasingly preva-
the vav1 promoter. lent (11 of 13 mice analyzed to date). As detailed in
Table 1, hematopoiesis was perturbed, with neutrophilia
(vavCreSocs3/fl, 6.0  4.8  109 cells/liter; vavCreResults
Socs3/fl, 1.7  1.9  109 cells/liter, n  8–11, p  0.05),
increased myelopoiesis in the bone marrow, and spleno-The vavCre Transgene Targets Cre Recombinase
megaly with prominent extramedullary hematopoiesis.Activity to Hematopoietic and Endothelial Cells
Erythropoiesis was diminished in the bone marrow butTo determine the cell type and tissue distribution of Cre
increased along with myelopoiesis in the spleen. Agingactivity to be expected in subsequent experiments tar-
vavCreSocs3/fl mice maintained a normal hematocritgeting Socs3, vavCre mice were first intercrossed with
(vavCreSocs3/fl, 45  3%; vavCreSocs3/fl, 46  3%,R26R reporter (loxP-stop-loxP-lacZ) mice (Mao et al.,
n  7–9 per group).1999). 	-galactosidase activity in adult tissues was used
as an indicator of Cre-mediated deletion. For each of three
independent founder vavCre lines, high 	-galactosidase Enhanced G-CSF-Induced Colony Formation
by SOCS3-Deficient BM Cellsexpression was observed in all hematopoietic cell lin-
eages (Figure 1A), endothelial cells, and testis (see Sup- To investigate whether late onset neutrophilia could be
a consequence of the aberrant actions of cytokines onplemental Figure S1 at http://www.immunity.com/cgi/
content/full/20/2/153/DC1), consistent with previous re- hematopoietic progenitors, we tested the responses of
hematopoietic progenitor cells in vitro to a range of he-ports for this promoter (Ogilvy et al., 1999) and for other
transgenic mice using the same vav promoter to drive matopoietic growth factors. When maximally stimulated
by GM-CSF, M-CSF, IL-3, IL-6, SCF, or combinationsCre expression (De Boer et al., 2003; Georgiades et
al., 2002). 	-galactosidase activity was not observed in thereof, the frequency of myeloid progenitor cells arising
from the bone marrow of young, healthy mice was nor-other adult cell types and tissues including hepatocytes,
myocytes, adipocytes, fibroblasts, epithelial cells, and mal. However, a selective increase was observed in the
number of vavCreSocs3/fl clonogenic cells capablerenal parenchymal cells (Supplemental Figure S1). Im-
portantly, 	-galactosidase expression was observed of forming colonies in response to G-CSF (Figure 3A).
Strikingly, the cellular content of the colonies inducedin 
99% of neutrophils, macrophages, T cells, and in
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Figure 1. vavCre Transgene Directs Expression of Cre Recombinase to Hematopoietic Cells
(A) The vav promoter drives Cre expression in hematopoietic cells from the bone marrow (BM), lymph nodes (LN), peripheral blood (PB),
peritoneal cavity (PC), and thymus (Thy) deleting a loxP-flanked stop sequence in cells from R26R reporter mice. Resultant 	-galactosidase
(	-gal) expression indicates this deletion. Ter119 staining identifies nucleated erythrocyte precursors and enucleate erythrocytes. The latter
cannot express 	-galactosidase whereas the vast majority of nucleated precursors express 	-galactosidase. B220 and Mac1 identify B
lymphocytes and macrophages, respectively. FSC represents cell size.
(B) Efficient deletion of Socs3fl allele in hematopoietic tissues by Cre. DNA was extracted from BM, thymus, spleen, lymph nodes, and
hematopoietic progenitor cells (linkit) of vavCreSocs3/fl or vavCreSocs3/fl mice. DNA was extracted from testis, liver, hepatocytes, heart,
lung, and brain of vavCreSocs3/fl mice. A 5 Socs3 probe distinguishes the wild-type (, 20 kbp), conditional (fl, 9 kbp), knockout (, 5 kbp),
and excised (, 4.9 kbp) alleles.
(C) Socs3/ cells are Socs3 deficient. Socs3 expression in bone marrow from vavCreSocs3/fl or vavCreSocs3/fl mice either unstimulated
or after G-CSF stimulation for 1–2 hr was analyzed by real-time PCR. Expression of the control housekeeping gene, Hprt, was assessed to
control for RNA integrity.
by G-CSF was 2-fold greater from SOCS3-deficient bone increased response was observed at both supramaxi-
mal and submaximal concentrations of G-CSF.marrow than for controls (Figure 3B). Again, selectivity
was observed for this phenotype, with no changes in In addition to the increased proliferation by SOCS3-
deficient progenitor cells stimulated by G-CSF, a subtlethe capacity for mature cell generation occurring when
the progenitor cells from the same bone marrow sample shift in differentiation was also evident. There was a signifi-
cant increase in the number and proportion of macro-were stimulated with GM-CSF, M-CSF, SCF, or combi-
nations of these other cytokines. The increased size phages within these colonies, as compared with the
nearly exclusively neutrophil composition of coloniesof the developing colonies was not unique to G-CSF
stimulation, however, and was also observed following derived from control progenitors. G-CSF-responsive
SOCS3-deficient progenitor cells generated higher pro-activation by IL-6 (Figure 3B).
To reduce the possibility that this 2-fold increase in portions of macrophage and granulocyte-macrophage
colonies than did control progenitor cells (Table 2).number of G-CSF-responsive progenitors simply reflected
enrichment for committed neutrophil progenitors or the
abnormal activity of some other cell type within the SOCS3- SOCS3-Deficient Myeloid Cells Are
Hyperresponsive to G-CSFdeficient bone marrow, cultures of purified linkit pro-
genitor cells were analyzed and an increased number To further exclude the possibility that the above obser-
vations reflected aberrant composition of the myeloidof G-CSF-responsive cells, both colony-forming cells
and total cells, was again observed (Figure 3C). This progenitor cell pool in young adult vavCreSocs3/fl
Immunity
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mice, additional evidence of enhanced in vitro re-
sponses to G-CSF were sought. As stated above, the
distribution of morphologically identifiable myeloid pre-
cursors was normal in young vavCreSocs3/fl mice.
Therefore, Gr-1-expressing myeloid cells (promyelo-
cytes, myelocytes, metamyelocytes, and neutrophils)
were sorted, and their proliferative responses to G-CSF
were assayed by tritiated thymidine incorporation. No
differences were noted in the composition of the sorted
precursor populations between genotypes (data not
shown). As illustrated in Figure 3D, thymidine incorpora-
tion by Socs3/ Gr-1 cells was significantly increased
in cells stimulated with several concentrations of G-CSF
but not IL-3. Furthermore, the survival of Socs3/ Gr-1hi
cells (a population highly enriched for neutrophils and
metamyelocytes, but not precursors with mitotic poten-
tial) was enhanced after 48 hr in culture in response to
G-CSF (Figure 3E).
To examine G-CSFR expression, bone marrow cells
from vavCreSocs3/fl and control mice were incubated
with radiolabeled G-CSF in the presence and absence
of excess unlabeled G-CSF. No differences in the num-
bers of G-CSFR were observed between genotypes
(vavCreSocs3/fl, 1699  72 cpm; vavCreSocs3/fl,
1884  248 cpm), eliminating this as an explanation for
the differences in cellular responses. In contrast, the
duration and intensity of STAT3 phosphorylation was
increased in lysates of bone marrow cells after a 15 min
pulse with G-CSF in vitro (Figure 3F). Activation of the
ras-MAPK pathway downstream of the G-CSF receptor
was not substantially affected in SOCS3-deficient cells.
Similar patterns of induction of phosphorylation of p42/
44 MAP kinase were observed for both SOCS3-deficient
and control cells. G-CSF-induced phosphorylation of
STAT1 or STAT5 was not detectable in lysates from
either SOCS3-deficient or control bone marrow cells
(data not shown). These in vitro data prove that expres-
sion of SOCS3 regulates both STAT3 phosphorylation
and the proliferation and survival of myeloid cells in
response to G-CSF.
SOCS3 Is Required to Negatively Regulate
Emergency Granulopoiesis
These in vitro data predict that SOCS3 might be required
to negatively regulate granulopoiesis under stress con-
ditions characterized by high levels of circulating G-CSF,
such as bacterial infection or burns. To mimic such an
emergency situation, vavCreSocs3/fl mice (with SOCS3-
deficient hematopoiesis) and vavCreSocs3/fl control
mice were injected with either pharmacological doses
of G-CSF or endotoxin-free diluent. Typically in such an
experiment, G-CSF is injected for 5 days (Roberts and
Metcalf, 1994). However, vavCreSocs3/fl mice devel-
oped severe lethargy and hind-leg paresis after 4 days
of G-CSF injection. As a result, mice were analyzed after
4 days of G-CSF injection rather than 5 days of G-CSF
injection. Socs3 wild-type mice never display such toxic-
ity from G-CSF, even at substantially higher doses, or
after prolonged injection (Roberts et al., 1997; Roberts
and Metcalf, 1994).
The responses to G-CSF expected of wild-type mice
were observed, and these were markedly accentuated
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in vavCreSocs3/fl mice, which exhibited enhanced
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Figure 2. Neutrophil Infiltration and Chronic
Inflammation in Aging vavCreSocs3/fl Mice
Photomicrographs of hematoxylin and eosin-
stained sections of various tissues from 17-
to 40-week-old vavCreSocs3/fl (b, d, f, and
h) and vavCreSocs3/fl (a, c, e, and g) mice
demonstrating: (a) a dominant granulocytic
population within the bone marrow; (c) a large
hematopoietic focus in the liver containing
predominantly neutrophils but also eosino-
phils, lymphocytes, macrophages, plasma
cells, and megakaryocytes; (e) an extensive
pericardial infiltrate of lymphocytes, macro-
phages, and fibroblasts; and (g) a chronic in-
flammatory infiltrate on the pleural surface of
the lung. Lymphocytes, macrophages, fibro-
blasts, neutrophils, and eosinophils are all
prominent. This pathology was not observed
in histology from control mice (b, d, f, and h).
neutrophilia, progenitor cell mobilization, and spleno- lacZ reporter mice, endothelial cells in vavCreSocs3/fl
mice are very likely to be Socs3 deficient, and thereforemegaly (Figure 4A). In addition, all vavCreSocs3/fl mice
displayed greatly increased neutrophilic infiltration of it is possible that the pathological responses observed
in the above experiment were contributed to by loss oftissues including the liver, spinal cord, and muscle (Fig-
ure 4B). This was particularly marked in two of the four SOCS3 expression in tissues other than the hematopoi-
etic system. A further caveat in interpreting these datamice examined, which displayed prominent focal aggre-
gates of neutrophils within the liver parenchyma. In one is the hemizygosity of SOCS3 in all other tissues and
the possibility that this may have contributed to themouse, whole areas of the bone marrow were replaced
with degenerating neutrophils and debri (Figure 4B). Evi- breadth of pathology observed. To confirm that the en-
hanced responses were principally intrinsic to the hema-dence of pathological neutrophil death was also seen
in the liver of this particular mouse. No such changes topoietic system, radiation chimeras were created in
which the hematopoietic compartment was SOCS3 defi-were observed in control mice injected with G-CSF. In
addition, the hematological and histological parameters cient, and all other tissues were wild-type. Socs3 wild-
type C57BL/6.SJL (Ptprca Pep3b [Ly5.1]) recipient miceof vehicle-injected vavCreSocs3/fl mice were identical
to vehicle-injected control mice (data not shown). were reconstituted with C57BL/6 (Ptprcb Pep3a [Ly5.2])
SOCS3-deficient or control fetal liver cells and thenOn the basis of our detailed survey of vavCreR26R
Immunity
158
Figure 3. SOCS3-Deficient Granulocytes Are Hyperresponsive to G-CSF
(A) Frequency of colony-forming cells (CFC) in response to a range of cytokines. 2.5  104 SOCS3-deficient or control BM cells were cultured
with specific stimuli in supramaximal concentrations for 7 days.
(B) Cellular content of SOCS3-deficient colonies relative to controls. Ten to eighty consecutive colonies from parallel cultures of BM cells of
each genotype were picked, pooled, and counted to calculate an average cellular content. Mean  SD of results from four to six mice per
genotype. *p  0.01.
(C) Number of G-CSF-responsive CFC (left) and total cells (right) generated after 7 days from 600 linkit progenitor cells in response to
supramaximal and submaximal concentrations of G-CSF.
(D) Proliferation of SOCS3-deficient Gr-1 myeloid cells in response to G-CSF and IL-3. 105 SOCS3-deficient or control Gr-1 myeloid BM
cells were cultured with G-CSF or IL-3 in various concentrations for 48 hr before cells were pulsed with 3[H]thymidine for 16 hr. Mean  SD
of triplicate cultures from one of three representative experiments.
(E) Survival of SOCS3-deficient and control Gr-1hi BM cells in response to G-CSF. Two hundred cells were cultured with G-CSF in various
concentrations, and the number of viable cells was counted on day 2.
(F) Activation of STAT3 and p42/44 MAP kinase in response to G-CSF. 2.5 106 bone marrow cells were pulsed for 15 min with 10 ng/ml G-CSF.
Lysates were analyzed by immunoblot using antibodies specific for phosphorylated and total STAT3 or p42/44 MAP kinase. Representative data
are from three independent experiments.
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Table 2. Aberrant G-CSF-Induced Production and Differentiation of Progenitor Cells Lacking SOCS3
Colony Composition
Granulocyte/
Stimulus Socs3 Genotype Total Blast Neutrophil Macrophage Macrophage Eosinophil Megakaryocyte
GM-CSF /fl 58  12 17  6 9  3 29  6 2  1
/ 76  12 1 1 27  4 14  4 33  8 2  2
G-CSF /fl 11  4 10  3 1  1 1  1
/ 32  7* 2 1 22  3* 3  2 6  4*
M-CSF /fl 55  12 4  3 3  1 48  13
/ 75  23 6  2 4  2 65  24
IL-3 /fl 61  12 6 2 13  4 11  2 21  7 2  1 8  1
/ 76  5 6 1 20  5 16  5 23  10 2  3 8  2
Unfractionated bone marrow cells (2.5  104) were cultured in the presence of a single cytokine in 0.3% agar/DME/FCS. After 7 days of
incubation, cultures were fixed, stained, and enumerated at 200magnification. Results represent mean SD from four mice of each genotype.
* p  0.05, Socs3/fl versus Socs3/.
treated with the same dose of G-CSF for 4 days and cruitment of neutrophils to the peritoneal cavity 3 hr
following the installation of casein was normal (vavCreanalyzed on day 5. Recipients of either SOCS3-deficient
or control vavCreSocs3/fl cells demonstrated efficient Socs3/fl, 5  4  106 neutrophils; vavCreSocs3/fl, 5 
4  106 neutrophils, n  5–10 per group). The percent-reconstitution by donor cells (
90% of cells in all hema-
topoietic lineages as judged by expression of Ly5.2). ages of dying cells within the freshly harvested perito-
neal lavages were similar between genotypes (data notMice reconstituted with SOCS3-deficient hematopoi-
etic cells were clearly hyperresponsive to G-CSF, with shown). To further investigate survival of SOCS3-defi-
cient neutrophils after exposure to inflammatory milieux,augmented progenitor cell mobilization and greater
splenomegaly than recipients of control cells (Figure we then cultured the peritoneal exudate cells at 37C
for 8 hr in media alone or media supplemented with5A), but some differences in hematological parameters
and in the degree of tissue pathology were evident be- either G-CSF or GM-CSF. The survival of the inflamma-
tory cells in media was unaffected by the absence oftween these mice and vavCreSocs3/fl mice (Figure 5B).
After G-CSF injection for 4 days, there was a near ab- SOCS3 (vavCreSocs3/fl, 40  11% PI; vavCre
Socs3/fl, 39  10% PI, n  4–7 per group), as wassence of mature neutrophils in the bone marrow of mice
reconstituted with SOCS3-deficient cells (data not shown). survival in the presence of G-CSF or GM-CSF (data not
shown). Finally, as a measure of the functional activitySurprisingly, these mature neutrophils were not de-
tected in increased numbers in the blood (Figure 5A) as of tissue neutrophils from sites of inflammation, super-
oxide production was measured. Superoxide produc-was observed for vavCreSocs3/fl mice injected with
G-CSF, but rather were found in large numbers in the tion by SOCS3-deficient neutrophils was normal in re-
sponse to fMLP, with or without G-CSF priming, as welltissues, particularly the liver and lungs (Figure 5B). Mice
injected with G-CSF for 8 days did display a neutrophilia as with a maximal stimulation by PMA (data not shown).
No superoxide production was detected with G-CSFgreater than observed for controls, ultimately recapitu-
lating the pattern of differences observed in vavCre priming alone (data not shown).
Socs3/fl mice. The degree of enhancement of G-CSF
response observed in transplant recipients of SOCS3- Discussion
deficient cells was not as marked as observed for
vavCreSocs3/fl over control mice. Further, neutrophil Taken together, these in vitro and in vivo data provide
direct proof that SOCS3 is a key negative regulator ofinfiltration of the spinal cord following G-CSF injection
was not observed in mice reconstituted with SOCS3- G-CSF-induced cellular responses. Signals emanating
from the G-CSFR induce proliferation, differentiation,deficient cells. These data indicate that, while the hema-
topoietic cell hyperresponsiveness to G-CSF is primarily survival, and mobilization of granulocyte progenitors
and neutrophils (Duhrsen et al., 1988; Liu et al., 1996;responsible for the aberrant tissue infiltration and pa-
thology, loss of SOCS3 expression by other cells, for Roberts and Metcalf, 1994; Semerad et al., 2002). Recent
studies using defined receptor mutations and condi-example, endothelial cells, must also contribute to the
severity of the phenotype. tional deletion of signaling intermediates, such as
STAT3, aimed at identifying the precise composition of
signaling cascades have revealed a complex regulatoryRecruitment and Activation of
SOCS3-Deficient Neutrophils pathway. Cellular responses to G-CSF clearly depend
on signaling events downstream of four tyrosine resi-The pathological tissue infiltration and damage by neu-
trophils observed in both G-CSF-injected mice with dues on the G-CSFR. Mutation of Tyr729 on the human
G-CSFR, the putative binding site for SOCS3, increasesSOCS3-deficient hematopoiesis and aging vavCre
Socs3/fl mice suggests that abnormalities in neutrophil STAT-mediated luciferase reporter activity, cell survival,
colony number, and colony size (Hermans et al., 2002).recruitment and activity may exist. In order to analyze
the survival and function of mature neutrophils in re- Previous studies of hematopoietic progenitor cells ge-
netically manipulated to receive signals from mutantsponse to an inflammatory stimulus, mice were injected
intraperitoneally with casein (Metcalf et al., 1996). Re- Tyr729Phe G-CSF receptors (Akbarzadeh et al., 2002)
Immunity
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Figure 4. G-CSF-Induced Neutrophil Infiltration into Tissues and Neutrophil Death Are Enhanced in the Absence of SOCS3
(A) Peripheral blood neutrophil and progenitor counts, and spleen weights from mice injected with vehicle or G-CSF (5 g/day i.p.) for 4 days.
Mean  SD of data from vavCreSocs3/fl or vavCreSocs3/fl mice. n  4 mice per group, *p  0.05.
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demonstrated a partial shift in differentiation within periments do not exclude a role for SOCS3-deficient
macrophages or lymphocytes and studies where theseemergent colonies from neutrophil to macrophage. Con-
sistent with those experiments, SOCS3-deficient pro- cell types are made selectively SOCS3 deficient are re-
quired to define their contribution. Further studies willgenitors displayed a similarly aberrant differentiation re-
sponse. G-CSF-responsive SOCS3-deficient progenitor also be needed to determine whether the defects in
granulopoiesis in SOCS3-deficient progenitors are duecells generated macrophage and granulocyte-macro-
phage colonies in greater proportions than SOCS3-suffi- to defects or changes in differentiation, cell cycle, or sur-
vival.cient control progenitor cells. These data provide evi-
dence that qualitative, as well as quantitative, changes Our data complement and clarify recent data describ-
ing the role of STAT3 in G-CSF signaling and granulo-in cellular responses to extracellular signals can be mod-
ulated by the expression of regulatory proteins such poiesis. STAT3-deficient mice have a neutrophilia, and
their myeloid cells are hyperresponsive to G-CSF andas SOCS3.
In the current study, we have shown that SOCS3 is a fail to induce expression of SOCS3 in response to G-CSF,
suggesting that one important function of STAT3 is tocritical regulator of G-CSF-induced myeloid progenitor
cell proliferation and mature cell survival as well as for induce SOCS3 (Lee et al., 2002). Our results support
this model and indicate that SOCS3 negatively regulatesestablishment of G-CSF-responsive progenitor cell num-
bers in the bone marrow. In vivo, these defects translate G-CSF signaling by inhibiting STAT3 activation. Further,
our data are consistent with the hypothesis that theinto significant abnormalities in G-CSF-induced emer-
gency granulocyte production. Unexpectedly, this was hyperresponsiveness to G-CSF observed in STAT3-defi-
cient mice is due to the lack of induction of SOCS3. Noassociated with G-CSF-induced toxicity, a previously
unreported observation for G-CSF-treated animals, even significant effect on the induction of p42/44 MAP kinase
phosphorylation following G-CSF stimulation was ob-at substantially higher doses of G-CSF, or in G-CSF-
transgenic animals or animals injected for a longer du- served. Additional studies will be required to determine
whether activation of other signaling pathways is sub-ration.
Anomalous responses to G-CSF were largely, but not stantially affected in the absence of SOCS3 and whether
these perturbations contribute to the phenotype wecompletely, intrinsic to the hematopoietic system. Ani-
mals transplanted with SOCS3-deficient fetal liver cells have observed.
These data predict that inhibition of SOCS3 may en-displayed pathological infiltration into multiple tissues
when injected with G-CSF for 4 days and signs of dis- hance clinically important G-CSF-dependent processes,
including neutrophil recovery after myelosuppressivetress after injection for 8 days. However, even with an
extended injection schedule, these mice did not display chemotherapy, or chemoradiotherapy as well as stem
and progenitor cell mobilization, and recovery from acutethe spinal cord infiltration by neutrophils observed in
vavCreSocs3/fl mice. This suggests a role for SOCS3 bacterial and/or fungal infection during neutropenia.
These data also predict that agonists of SOCS3 mayin the regulation of G-CSF or other cytokine responses
in nonhematopoietic tissues. Given that endothelium is reduce unwanted clinical sequelae of inflammatory pro-
cesses characterized by neutrophil accumulation anda critical mediator of neutrophil migration to the tissues
and that the vavCre transgene is expressed in endothe- activation, such as engraftment syndrome following al-
logeneic or autologous stem cell transplantation, pulmo-lium, it is possible that the differences in G-CSF-induced
pathology observed between the two models can be nary inflammation observed after recovery from severe
neutropenia, acute arthritis, and inflammatory bowelattributed to deletion of Socs3 in endothelium. This will
be addressed in more detail by G-CSF treatment of disease (Shouda et al., 2001).
Finally, it is unlikely that hyperresponsiveness tocontrol and SOCS3-deficient mice following reciprocal
transplantation of SOCS3-deficient and control bone G-CSF fully explains the pathology observed in aging
mice lacking expression of SOCS3 in the hematopoieticmarrow.
Which hematopoietic cells are responsible for the tis- compartment. As well as cumulative neutrophil infiltra-
tion into varied tissues, tissue damage due to chronicsue damage observed in response to G-CSF administra-
tion? Neutrophils are certainly involved as they dominate inflammation was routinely observed, implying that ab-
errant responses by SOCS3-deficient T cells, B cells,the pathology and are intrinsically hyperresponsive to
G-CSF in vitro. It is possible that the tissue infiltration eosinophils, or macrophages to a variety of other cyto-
kines are likely to be contributing to the final pathology.and destruction by neutrophils in G-CSF-treated SOCS3-
deficient mice may also be compounded by aberrant Given the suggestive data linking SOCS3 in the regula-
tion of numerous cytokines derived from in vitro overex-recruitment or activation of neutrophils, although our
initial data addressing these issues do not indicate en- pression systems and the recent data confirming a phys-
iological role for SOCS3 in the regulation of IL-6 signalinghanced recruitment or superoxide production. Our ex-
(B) Photomicrographs of hematoxylin and eosin-stained sections of various tissues from G-CSF-injected vavCreSocs3/fl control mice (a, c,
e, and g) and vavCreSocs3/fl mice (b, d, f, and h) demonstrating: (b) neutrophil debris in the bone marrow and pronounced neutrophil
infiltration into the adjacent muscle tissue; (d) increased neutrophil numbers in the alveolar wall of the lung; (f) a neutrophil focus in the liver;
and (h) increased myelopoiesis, edema, and associated destruction of the spinal cord of vavCreSocs3/fl mice. The large arrows (g and h)
indicate spinal cord, and the small arrows demarcate the epidural space, which in vavCreSocs3/fl mice is replaced by myeloid infiltrate (h).
None of the pathological features observed in vavCreSocs3/fl mice injected with G-CSF were observed in Socs3 wild-type mice injected
with G-CSF (a, c, e, and g) or in vavCreSocs3/fl mice injected with vehicle (data not shown). Data are representative of four mice.
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Figure 5. Enhanced In Vivo Responses Induced by G-CSF in Mice with SOCS3-Deficient Hematopoiesis
(A) Peripheral blood neutrophil and progenitor counts, and spleen weights from Ly5.1 mice transplanted with SOCS3-deficient or wild-type
Ly5.2 fetal liver cells and injected at least 3 months posttransplantation with vehicle or G-CSF (5 g/day i.p.) for 4 or 8 days. n  6–8 mice
(vehicle and 4 days) or 2–3 mice (8 days) per group, *p  0.05.
(B) Photomicrographs of hematoxylin and eosin-stained sections of tissues from mice, transplanted with SOCS3-deficient (b, d, f, and h) or
wild-type (a, c, e, and g) fetal liver cells, and then injected with G-CSF for 8 days. (b) Neutrophil debris in the bone marrow and pronounced
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was quantified by comparison with the expression of the single-(Alexander, 2002; Croker et al., 2003; Lang et al., 2003;
copy housekeeping gene, Hprt.Yasukawa et al., 2003), further experiments addressing
the role of SOCS3 in specific circumstances are required.
Clonogenic Assays
Nevertheless, the spontaneous and G-CSF-induced in 2.5  104 bone marrow cells or 5  104 spleen cells were resus-
vivo pathology reported here, in conjunction with the pended in 0.3% agar and modified Dulbecco’s medium (DME), sup-
unequivocal in vitro data, clearly indicate that an impor- plemented with 20% fetal calf serum (Metcalf, 1984). Cells were
incubated for 7 days at 37C with 10 ng/ml recombinant murine (rm)tant physiological function of SOCS3 is the negative
GM-CSF, rmM-CSF or recombinant human G-CSF, 100 ng/ml IL-6,regulation of G-CSF signaling.
25 ng/ml rmIL-3 or 100 ng/ml rmSCF, or combinations thereof. At
day 7, colonies were enumerated and either fixed in glutaraldehydeExperimental Procedures
and stained for differential counting (Metcalf, 1984), or picked,
pooled, and counted to determine the cellular content of colonies.Generation of Mice with a Socs3-Deficient
Peripheral blood progenitors were enumerated by culturing 5–20 lHematopoietic System
of blood in standard colony assays for 7 days, prior to fixation,Generation of mice bearing null (Socs3) and loxP-flanked condi-
staining, and counting at 40 magnifications (Roberts and Metcalf,tional (Socs3fl) alleles of Socs3 on a C57BL/6 inbred background
1994). In specific experiments, cultures were initiated with 600linkithave been previously described (Croker et al., 2003; Roberts et al.,
progenitor cells.2001). In the Socs3fl allele, the entire Socs3 coding region is flanked
by loxP sites, and expression of Cre renders the allele functionally
LacZ Assaysnull. In order to generate a hematopoietic-specific deletion of Socs3,
	-galactosidase assays were performed as described previouslywe created transgenic mice in which Cre recombinase expression
(Elefanty et al., 1999).was restricted to cells of the hematopoietic and endothelial lineages
(vavCre mice). A 11.2 kbp plasmid, containing elements of the
Proliferation Assaysvav1 promoter and a human CD4 reporter (Ogilvy et al., 1999), was
Gr1-positive bone marrow cells were sorted, and purity was ana-digested with SfiI and NotI to replace the human CD4 reporter with
lyzed by cytology. Cells (105) were incubated in 0.01–10 ng/ml G-CSFa nls-Cre (nuclear localization signal-Cre) recombinase cassette.
or 2.5–25 ng/ml IL-3 for 48 hr at 37C. Cells were pulsed with 1 CiThe pIC19H (prokaryotic) sequences were removed by restriction
[3H]thymidine for 16 hr, transferred to Inotech glass fiber filters,digestion with Hind III and the remaining 8.2 kbp fragment was
and counted in a TopCount NXT Microplate Scintillation Counterpurified from low-melt agarose using agarase (New England Bio-
(Packard). All samples were analyzed in duplicate or triplicate.labs). The purified DNA was dialysed for 12 hr in microinjection
buffer (10 mM Tris/HCl [pH 7.4], 0.1 mM EDTA) and adjusted to
Survival Assays2 g/ml for pronuclear injection into C57BL/6 eggs. Digestion of
Survival assays were performed as described (Begley et al., 1986).genomic DNA from founders, coupled with a Cre probe, was used
Bone marrow Gr1hi cells (neutrophils and metamyelocytes but notto identify transgenic offspring by Southern blot. On the basis of
granulocytes with mitotic potential) were cultured in DME/2%FCSthe expression of the vavCre transgene in R26R lacZ reporter mice
and various concentrations of G-CSF. Viable cell numbers were(Soriano, 1999), three independent vavCre transgenic lines (15, 48,
counted on days 2, 3, and 4. Survival of peritoneal cavity exudateand 71) were selected to use for intercrossing with mice bearing
cells from casein-injected mice was assessed using flow cytometrymutant Socs3 alleles. Mice with a deletion of Socs3 in the hemato-
and propidium iodide (PI). Cells were incubated at 37C/5%CO2 forpoietic system were generated by crossing mice with two copies
8 hr in Hank’s buffered saline solution (HBSS) supplemented withof the loxP-flanked Socs3 conditional allele (Socs3fl/fl) with mice
1% glucose, 0.1% BSA, and either saline, 10 ng/ml G-CSF, or 10expressing the vavCre transgene and bearing one Socs3 null allele
ng/ml GM-CSF.(Socs3) and one Socs3 wild-type allele (Socs3). The resultant
progeny were analyzed at 8 weeks of age or between 17 and 40
Superoxide (O2) Productionweeks of age. Hematopoietic cells were analyzed by flow cytometry
Superoxide production in neutrophils (3  106 cells/ml) was as-as previously described (Croker et al., 2002) and by cytology follow-
sessed by the superoxide dismutase-inhibitable reduction of cyto-ing May Gru¨nwald (eosin methylene blue, Merck, Germany) and
chrome c (75 M). Neutrophils were primed with 10 ng/ml G-CSFGiemsa (Merck, Kilsyth, Victoria, Australia) staining. For reconstitu-
for 15 min and activated with 1 M fMLP or 200 pg/ml PMA (Sigma).tion experiments, congenic C57BL/6.SJL (Ptprca Pep3b [Ly5.1]) mice
Changes in absorbance at 550 nm were monitored at 37C on awere reconstituted with 3  106 C57BL/6 (Ptprcb Pep3a [Ly5.2]) fetal
Cary 50 UV-Vis spectrophotometer.liver cells from E14 embryos of either vavCreSocs3/fl or vavCre
Socs3/fl genotype after two 5.5 Gy doses of irradiation. Analyses
Immunoblottingof data were performed using a Student’s t test. Animal experiments
Bone marrow cells (2.5  106) in Dulbecco’s modified Eagle’s me-were done with the approval of the Melbourne Health Research
dium (DMEM) supplemented with 0.1% bovine serum albumin wereDirectorate Animal Ethics Committee.
pulsed with 10 ng/ml G-CSF for 15 min. SDS-PAGE of total cell
lysates and immunoblots to phospho-STAT3, STAT3, phospho-p42/Real-Time PCR
44, and p42/44 (Cell Signaling, Beverly, MA) were performed ascDNA was prepared from 2 g total RNA derived from 3  106
described (Brysha et al., 2001).Socs3/fl or Socs3/ bone marrow cells stimulated with 10 ng/ml
G-CSF. Socs3 and Hprt levels were quantified by real-time PCR
analysis using the Rotor Gene 2000 (Corbett Research, Mortlake, In Vivo Responses to G-CSF
Seven- to eleven-week-old mice were injected intraperitoneallyAustralia). PCR was performed using the following primers and cy-
cling conditions: Hprt, 5-CACAGGACTAGAACACCTGC-3 (forward) twice daily with 2.5g rhG-CSF (lenograstim, AMGEN). These exper-
iments were performed as previously described (Roberts et al., 1997;and 5-GCTGGTGAAAAGGACCTCT-3 (reverse); Socs3, 5-GGCCAC
CCTCCAGCATCTTTGTCG-3 (forward) and 5-GTGGCAGCTCCCC Roberts and Metcalf, 1994), except that mice were only injected for
4 days and analyzed on the fifth day. Transplanted mice were in-CTCCCCTCAG-3 (reverse), 40 cycles at 94C for 15 s, 53C (Hprt)
or 70C (Socs3) for 30 s, and 72C for 30 s. Expression of Socs3 jected with G-CSF at least 3 months following reconstitution.
neutrophil infiltration into the adjacent muscle tissue; (d) an extensive neutrophilic infiltrate destroying the lung alveoli; (f) a foci of neutrophils
within the liver parenchyma; and (h) myeloid cells in the epidural space adjacent to the spinal cord of Ly5.1 mice with SOCS3-deficient
hematopoiesis. None of the pathological changes seen in (b), (d), (f), and (h) were seen in control mice injected with G-CSF (a, c, e, and g) or
mutant mice injected with vehicle.
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